Managing Your Environmental Isolates

Similar documents
Managing Your Environmental Isolates

Robert Westney, M.S., RAC, CMQ/OE Director of Quality and Operations Cryologics, Inc. March 7, 2017

Quality Control Microorganism Product Guide. Convenience with Confidence

FDA s Guidance for Industry

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Microbiology Testing: USP requirements for Sterile and Nonsterile Preparations Webinar Q&A

Hot Topics in Drug Product Process Validation: A Reviewer s Perspective

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services

MICROBIOLOGICAL CULTURE MEDIA

INSTRUCTIONS FOR USE

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

LUNCH AND LEARN. September 11, CE Activity Information & Accreditation

Q8 Pharmaceutical Development

DISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT

How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant

Residue removal in Cleanroom Environments

Today s Topics. General Quality Control Best Practices. Practices Antimicrobial Effectiveness Testing(AET) Best Practices Environmental Isolates

Bioburden Contamination Control: A Holistic Overview

USP <1116> and Contamination

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.

Overview of Inspection Issues with Legacy Products

INSTRUCTIONS FOR USE

Avoid recurrent microbial contamination using trending of historical data. El Azab Walid Technical Service Manager STERIS

Media Fill A Process Simution. Presented By Shikha Chauhan

ATCC Microbiology Best Practices for Stock Maintenance. C a r o l H o r t o n M a r ke t i n g M a n a g e r, AT C C

Complaints Investigations Root Cause Analysis

Disinfection Qualification Testing

Microbiological Cleaning Method Validation

The Microbiological Requirements of a Stability Study. Ngoc Anh-Thu Phan 19 th June 2012

EZ-CFU Microorganisms

WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

Providing clear solutions to microbiological challenges TM. cgmp/iso CLIA. Polyphasic Microbial Identification & DNA Fingerprinting

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A

Guidance for Industry

Chapter 9 Controlling Microbial Growth in the Environment. 10/1/ MDufilho

INSTRUCTIONS FOR USE. EZ-CFU Microorganisms INTENDED USE FORMULA COMPONENTS

EU Guidance / Q&A. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin

Change Control Overview

Contact details: Anna Silvani

Preservative Testing Choice of Challenge Isolates

Microbiological Consideration for Non-Sterile Pharmaceutical

INSTRUCTIONS FOR USE LYFO DISK KWIK-STIK KWIK-STIK PLUS. n LYFO DISK Microorganisms n KWIK-STIK Microorganisms n KWIK-STIK Plus Microorganisms

How to Select a Microbiology Contract Testing Laboratory? Tony Cundell, Ph. D. Microbiological Consulting, LLC Scarsdale, New York

Guidance. Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE

Inspections, Compliance, Enforcement, and Criminal Investigations

Disinfectant Qualification A Multifaceted Study

STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS

ISO 13485:2016 The Final Countdown

A Case Study for an Improved Approach to Cleanroom Disinfection, Minimizing the Impact and Reducing Downtime

The University of Jordan

Risk based approaches for a sterility assurance application review: a microbiologist s perspective Dr. Yeissa Chabrier Roselló

Pharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD

Overview of Inspection Issues with Legacy Products. Barbara Breithaupt Consumer Safety Officer

Case study Microbiological excursion during a phase I PQ of a WFI system. Walid El Azab Technical Service Manager STERIS Life Science

5.1.1 & Changes started in 2008 and were mainly driven under the Chairmanship of Prof Hans van Doorne 11/10/2017

The Most Probable Number Method and Its Use in QC Microbiology

Growth Promotion Test Guide for Media Used in Sterility Tests

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

ADVANCED TESTING LABORATORY

Cleanroom Contamination including Mould/Fungal contamination

HVAC and Risk Management RACI Meeting 7 th December Agenda. Design. Project Management. Context. Qualification. Construction

Global Biological Resource Leader

Test Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces

Current Considerations on Chemistry, Manufacturing and Control of Cell Therapy Products (CTPs)

The Application of Pharmaceutical cgmp to Live Bacterial Products. James Harris Business Development Manager

INSTRUCTIONS FOR USE. EZ-CFU One Step Microorganisms INTENDED USE FORMULA COMPONENTS

Industry Case Study: A Microbial Investigation of Contamination by Burkholderia multivorans. Jim Klein and Geert Verdonk Merck & Co., Inc.

Industry Perspective on PET Manufacturing Comparison of EU and US

Public Health Consumer Protection Program

Responding to an FDA 483

January 22, WARNING LETTER CHI-03-09

The aim of antimicrobial efficacy testing (AET) performed during

Pharmacies and Outsourcing Services

The Control of Microbial Growth

The Control of Microbial Growth

Curriculum Vitae. SENIOR VICE PRESIDENT JAMES P. KULLA Mobile Phone:

Appendix J - Guidelines for the Development of an Environmental Sampling Program

Webinar Expert Module 3: GMP Inspections Dupont

This document is a preview generated by EVS

Human Microbiota: proof of concept to production. Michael van der Horst Process Engineer Technical Operations SynCo Bio Partners B.V.

Proposed Revision of USP General Chapter Radiopharmaceuticals for Positron Emission Tomography Compounding <823>

LEGAL REQUIREMENTS FOR STABILITY

Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC

Auditing Your Laboratory for Compliance with the FDA Dietary Supplement GMP s

Contents. Contents (13) 1 Production (23)

Quality aspects Overview. QP declaration

FOOD AND DRUGS AUTHORITY

Preservative Challenge Testing and Compendia: Efficient Efficacy

Guidance for Industry Process Validation: General Principles and Practices; A Contract Manufacturing Organization's Approach

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016

Packaging Operations Technical Subcommittee

CGMP Requirements for Investigational Products

Environmental Monitoring of Aseptic Processing Areas - 1

MICROBIOLOGICAL BEST LABORATORY PRACTICES USP <1117>

INTRODUCTION Sanitization sterilization Antibiotics Bactericidal Bacteriostatic Antiseptics disinfectants

THE GMP HANDBOOK ANNEXES. g o o d m a n u fac t u r i n g p r ac t i c e. quality systems for the pharmaceutical industry.

The ABCs and Challenges of GMP The American Experience

Transcription:

Managing Your Environmental Isolates

Good Testing Practices Good practice includes the periodic challenge of media with low levels of organisms. This includes USP indicator organisms as well as normal flora. -U.S. Food and Drug Administration: Guide to Inspections of Microbiological Pharmaceutical Quality Control Laboratories (1993)

Detection & Identification It is important to know: What is in the cleanroom environment The effectiveness of cleaning and sanitization procedures The source of the contaminate

Sources of Contamination Personnel Utilities Raw Materials Facility Equipment Common culprits: Personnel Air Water Processes Case Studies of Microbial Contamination in Biologic Product Manufacturing Suvama, et al., American Pharmaceutical Review, 2011. Processes

Tracking and Trending Effective tracking and trending analysis is essential An early warning signal for system failures Provides clues to contamination source

Is It Objectionable? 21 CFR 211.84(d)(6) Each lot of a component, drug product container, or closure with potential for microbiological contamination that is objectionable in view of its intended use shall be subjected to microbiological tests before use. 21 CFR 211.113(a) Appropriate written procedures, designed to prevent objectionable microorganisms in drug products not required to be sterile, shall be established and followed. 21 CFR 211.165(b) There shall be appropriate laboratory testing, as necessary, of each batch of drug product required to be free of objectionable microorganisms. What is an Objectionable Organism? Sutton, Scott, Ph.D., American Pharmaceutical Review, October 2012.

Is It Objectionable? Ultimately, the laboratory must determine if the organism is objectionable Sterile vs. non-sterile products Intended use Intended recipient Intended route of administration

Managing Risk with Testing Disinfectant Challenge Test Growth Promotion Test Antimicrobial Effectiveness Test

Disinfectant Challenge Testing the most frequently isolated microorganisms from an environmental monitoring program may be periodically subjected to use-dilution testing with the agents used in the disinfection program to confirm their susceptibility, as there are real differences among different species in resistance to the lethal effects of different sanitizers. USP 38 <1072> Disinfectants and Antiseptics, 2015

Selecting the Right Isolates for Disinfectant Testing Provide scientific rationale for the organisms used for your testing Choose strains that represent common organisms isolates from the facility Choose organisms that are common contaminates or high risk for the products manufactured at the facility Avoid unnecessary audit findings

Growth Promotion Testing The media used in the following tests should be capable of growing recommended indicator organisms and environmental isolates Environmental monitoring Media fills Sterility Test

Growth Promotion Testing The growth promotion test is a procedure used to demonstrate the media in the microbiological environmental monitoring program or in media-fill runs, are capable of supporting growth of indicator microorganism and of environmental isolates from samples obtained through the monitoring program or their corresponding ATCC strains. USP 38 <1116> Aseptic Processing Environments, 2015

Antimicrobial Effectiveness Testing The standard battery of challenge organisms need not prevent the inclusion of other species of microorganisms if deemed useful to measure the biological activity of the preservative system for a specific product. USP <51> Antimicrobial Effectiveness Testing, 2015 Product Product

Antimicrobial Effectiveness Testing Products of any category whose formulas establish more extreme environmental conditions (ph, water activity, specific formula conditions) may warrant addition of isolates capable of survival if not growth under such extreme conditions allowing measure of preservative efficacy versus intrinsic hostility. Antimicrobial Effectiveness Testing: Culture Selection and Inoculum Preparation, Phil Geiss, 2013

Why Use Environmental Isolates? Environmental isolates may be more resistant to disinfectants because they adapt to the environment and limited nutrients The isolates may need special conditions to grow Isolates can be harder to detect in your product

Wild Strains versus Domesticated Strains Wild microorganisms are able to modify their properties according to their nutrient supply (for example, phase variation in bacteria) and, in particular, are able to adapt to limited nutrients. Multicellular microorganisms: laboratory versus nature, Zdena Palková, EMBO Reports, 2004 There is a strong argument that environmental isolates are the best challenge to media and for validation studies like sterility test validation. They are the most sensitive microorganisms, having become recently exposed to disinfectants, particular soils etc. The Use of Environmental Isolates, Tim Sandle, Pharmaceutical Microbiology blog, January 10, 2010

Preserving Isolate Options Professional Preservation Services Long-Term Preservation Methods Short-Term Preservation Methods

Short-Term Preservation Methods Preservation Method Pros Cons Sub-culturing/ Refrigeration + Low tech - Highest risk of mutation - Risk of contamination - Must remain within 5 passages per USP Sub-zero Freezing (-20 C) + Viability can be maintained for 1-2 yrs. - Ice crystals and electrolyte fluctuations can damage organism - Risk of contamination - Freezer cost and maintenance

Long-Term Preservation Methods Preservation Method Ultra-low Freezing Cryogenic Freezing Pros + Reduces probability of mutation + Longer survival rate Cons - Labor intensive - Costly - Must closely monitor temperature - Vulnerable to power outages and failures Lyophilization + Reduced risk of intracellular ice crystallization; halts all enzymatic and non-enzymatic reactions + Easy storage - Requires specialized equipment - Labor intensive - Experimentation required; strains react differently to process

Professional Preservation Services Turn-key processes for isolate management Isolate identification Isolate manufacturing Isolate storage Characterizatio n and seed preparation Customized format production Shipping, distribution and storage

Step 1: Characterization and Preproduction Strain characterization Determine final isolate specifications for testing Media and conditions should be mimicked Packaging needs Distribution requirements Establish a project timeline

Step 2: Production Seed stock is established 3-phase quality control checks Before preservation After preservation After packaging Seed stock for storage and future use Stock for immediate production

Step 3: Certificates and Reports Certificate of Analysis Mean Assay Value and statistics Complete DNA sequencing report Organisms identification Biochemical testing results

Step 4: Shipping and Storage Isolate is packaged, shipped and distributed Isolates are maintained for future use

Cost Analysis for Outsourcing Costs of Manual Prep Labor (hrs x wages) - Handling isolates - Quantitating samples - Identification for mutation - QC for contamination - Record keeping for audits Freezer 3 rd party identification Laboratory supplies Higher Cost Vs. Costs of Outsourcing Project price Identification (included) Maintenance & storage (included) Lower Cost

Considerations for Outsourcing Accreditation Experience Test-ready format options Quality reputation Finished goods storage Technical support and service Distribution options Product warranty

Final Thoughts All environmental isolates pose risk in aseptic manufacturing Current regulations require the use of isolates in testing Managing isolates can be difficult and expensive, but there are accredited providers to help

Contact Info Kelly Hedlund Midwest Regional Sales Manager Territory - IL, IN, MI, MN, ND, OH, WI Cell: 320-249-4761 Email: khedlund@microbiologics.com Website: www.microbiologics.com/custom-solutions

Thank you!